Literature DB >> 8050438

Fulminant septicaemia due to Streptococcus milleri infection in a previously healthy adult.

P G Flanagan1, R G Mills.   

Abstract

A 59-year-old previously healthy female developed purulent pharyngitis leading rapidly to neck cellulitis, septicaemic shock and fatal cardiac arrest despite appropriate antibiotic therapy. Streptococcus milleri was isolated from a submandibular abscess, cellulitic neck tissue and blood cultures. Fulminant septicaemia due to this group of organisms is relatively uncommon and usually occurs in the immunocompromised or otherwise chronically unwell.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050438     DOI: 10.1007/bf01974544

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

Review 1.  Streptococcus milleri group: renewed interest in an elusive pathogen.

Authors:  S C Piscitelli; J Shwed; P Schreckenberger; L H Danziger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

2.  'Toxic strep syndrome' associated with group C Streptococcus.

Authors:  P Keiser; W Campbell
Journal:  Arch Intern Med       Date:  1992-04

Review 3.  Do the beta-hemolytic non-group A streptococci cause pharyngitis?

Authors:  N Cimolai; R W Elford; L Bryan; C Anand; P Berger
Journal:  Rev Infect Dis       Date:  1988 May-Jun

4.  Fatal infection in neonates of 26 weeks' gestation due to Streptococcus milleri: report of two cases.

Authors:  R A Cox; K Chen; A L Coykendall; P Wesbecher; V C Herson
Journal:  J Clin Pathol       Date:  1987-02       Impact factor: 3.411

5.  Fulminant neonatal sepsis due to Streptococcus milleri.

Authors:  R C Spencer; C S Nanayakarra; A J Coup
Journal:  J Infect       Date:  1982-01       Impact factor: 6.072

6.  Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.

Authors:  L S Elting; G P Bodey; B H Keefe
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

Review 7.  Occurrence and pathogenicity of the Streptococcus milleri group.

Authors:  J Gossling
Journal:  Rev Infect Dis       Date:  1988 Mar-Apr

8.  Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections.

Authors:  R A Whiley; D Beighton; T G Winstanley; H Y Fraser; J M Hardie
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

9.  Clinical and bacterial features of infections caused by Streptococcus milleri.

Authors:  J M Molina; C Leport; A Bure; M Wolff; C Michon; J L Vilde
Journal:  Scand J Infect Dis       Date:  1991

10.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

  10 in total
  1 in total

1.  Species belonging to the "Streptococcus milleri" group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens.

Authors:  C Bantar; L Fernandez Canigia; S Relloso; A Lanza; H Bianchini; J Smayevsky
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.